Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DAVENPORT, J. G.
Right arrow Articles by SUMI, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DAVENPORT, J. G.
Right arrow Articles by SUMI, S. M.
NEUROLOGY 1976;26:919
© 1976 American Academy of Neurology

‘Giant axonal neuropathy’ caused by industrial chemicals

Neurofilamentous axonal masses in man

JOHN G. DAVENPORT, M.D., C M., DONALD F. FARRELL, M.D. and S. MARK SUMI, M.D.

From the Division of Neurology, Department of Medicine and the Laboratory of Neuropathology, Department of Pathology, University of Washington School of Medicine, Seattle, Washington.

Symmetrical polyneuropathy developed in two patients after they had been in contact with acrylamide and methyl n-butyl ketone, respectively. In sural nerve biopsy material from both patients, electron microscopy showed frequent focal axonal swellings containing masses of neurofilaments. Some axons undergoing axonal degeneration also were seen. These morphologic features are identical to those produced in experimental animals after exposure to these chemicals and are similar to those found in n-hexane neuropathy and in the three reported cases of giant axonal neuropathy. Sural nerve biopsy is an important diagnostic test in identifying cases of peripheral neuropathy caused by these chemicals.

Requests for reprints should be addressed to Dr. Sumi, Department of Medicine, Division of Neurology, University of Washington, Mail Stop RG-20, Seattle, Washington 98195.

Presented at the twenty-eighth annual meeting of the American Academy of Neurology, Toronto, Canada, April 1976.

This study was supported in part by USPHS Clinical Neurology Training Grant NS-05067-19.

Received for publication December 24, 1975.




This article has been cited by other articles:


Home page
J Child NeurolHome page
W. H. Hoffman, J. E. Carroll, G. Y. Perry, P. L. Hartlage, S. J. Kaminer, N. C. Flowers, S. J. Oh, and D. R. Kelly
Giant Axonal Neuropathy in a Child With Insulin-Dependent Diabetes Mellitus
J Child Neurol, May 1, 1995; 10(3): 250 - 253.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1976 by AAN Enterprises, Inc.